Comparative Effectiveness Research Trial of Alzheimer's Disease Drugs View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2011-2015

ABSTRACT

Conduct a comparative effectiveness clinical trial of medication treatment for behavioral symptoms of Alzheimer's disease in a group of real-world memory care clinics with enhanced access to the Indiana Network for Patient Care. Detailed Description The overarching goal of this proposal is to enhance the existing information technology infrastructure in Central Indiana to improve the nation's capacity to conduct comparative effectiveness research (CER). Consistent with the instructions in RFA-HS-10-005, the investigators propose to apply these new capacities to a novel CER project evaluating treatment for Alzheimer's disease. Alzheimer's disease has been identified as a first quartile CER priority. This proposal represents collaboration between the Medical Informatics Program at the Regenstrief Institute, Inc (a world leader in health information technology) and two Indiana University research programs: the Center for Aging Research and the Division of Clinical Pharmacology. These programs have an established track record in research relevant to under-served populations. Thus, this proposal combines considerable investigator, environment, and research strengths to continue to build a novel CER infrastructure in support of the nation's evidentiary CER priorities. Throughout this proposal, the investigators use the AHRQ definition of CER: the conduct and synthesis of research comparing the benefits and harms of different interventions and strategies to prevent, diagnose, treat and monitor health conditions in real world settings." The investigators also refer to a clinical trial of medication treatment for behavioral symptoms of Alzheimer's disease as the specific CER proposed to demonstrate the potential of our new infrastructure. However, the investigators stress that the enhancements proposed to existing infrastructure would support a broad portfolio of CER across an array of priority conditions. The investigators are also proposing enhancements in our privacy and confidentiality technology that would allow researchers from across the country to access de-identified data in support of CER. In summary, the investigators are proposing to add new CER knowledge on Alzheimer' disease and thereby field test new information technology capacities important to a wide range of CER projects while also increasing our capacity to provide data and opportunities for nationwide CER. The derivation of meaningful and actionable evidence from CER ultimately depends on capturing relevant, comprehensive and accurate data about treatment decisions, patients' clinical status, their care processes and environment, and the health outcomes they experience and value. Such data must be tracked longitudinally in order to determine temporal relationships, cause-effect paradigms, and the efficacy of specific clinical interventions in the context of other conditions, interventions, and goals of care. At Indiana University and the Regenstrief Institute, the investigators have four decades of experience and a well-documented, world-class clinical informatics and research infrastructure for capturing, storing, querying and analyzing treatment patterns and patients' clinical outcomes. The maturation of this health information technology is now embodied within the Indiana Network for Patient Care (INPC), a fully-operational regional health information exchange. The investigators are well positioned to expand and leverage this infrastructure in support of local and national multi-site clinical trials in comparative effectiveness. The specific aims of this proposal are to: 1.0 PROSPECT STUDY: Enhance our existing information technology infrastructure to: 1. provide de-identified access to the INPC database for CER work 2. capture, store, and track a broader array of health care outcomes important to patients and their caregivers (e.g. behavioral symptoms due to dementia); 3. support providers' and caregivers' and researchers' increasing need to work in teams by providing new tools for communication and co-management (e.g. collaborative care and research) 2.0 COMET-AD STUDY: Conduct comparative effectiveness clinical trial of medication treatment for behavioral symptoms of Alzheimer's disease in a group of real-world memory care clinics with enhanced access to the Indiana Network for Patient Care. More... »

URL

https://clinicaltrials.gov/show/NCT01362686

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3177", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/2790", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "Conduct a comparative effectiveness clinical trial of medication treatment for behavioral symptoms of Alzheimer's disease in a group of real-world memory care clinics with enhanced access to the Indiana Network for Patient Care.\n\nDetailed Description\nThe overarching goal of this proposal is to enhance the existing information technology infrastructure in Central Indiana to improve the nation's capacity to conduct comparative effectiveness research (CER). Consistent with the instructions in RFA-HS-10-005, the investigators propose to apply these new capacities to a novel CER project evaluating treatment for Alzheimer's disease. Alzheimer's disease has been identified as a first quartile CER priority. This proposal represents collaboration between the Medical Informatics Program at the Regenstrief Institute, Inc (a world leader in health information technology) and two Indiana University research programs: the Center for Aging Research and the Division of Clinical Pharmacology. These programs have an established track record in research relevant to under-served populations. Thus, this proposal combines considerable investigator, environment, and research strengths to continue to build a novel CER infrastructure in support of the nation's evidentiary CER priorities. Throughout this proposal, the investigators use the AHRQ definition of CER: the conduct and synthesis of research comparing the benefits and harms of different interventions and strategies to prevent, diagnose, treat and monitor health conditions in real world settings.\" The investigators also refer to a clinical trial of medication treatment for behavioral symptoms of Alzheimer's disease as the specific CER proposed to demonstrate the potential of our new infrastructure. However, the investigators stress that the enhancements proposed to existing infrastructure would support a broad portfolio of CER across an array of priority conditions. The investigators are also proposing enhancements in our privacy and confidentiality technology that would allow researchers from across the country to access de-identified data in support of CER. In summary, the investigators are proposing to add new CER knowledge on Alzheimer' disease and thereby field test new information technology capacities important to a wide range of CER projects while also increasing our capacity to provide data and opportunities for nationwide CER. The derivation of meaningful and actionable evidence from CER ultimately depends on capturing relevant, comprehensive and accurate data about treatment decisions, patients' clinical status, their care processes and environment, and the health outcomes they experience and value. Such data must be tracked longitudinally in order to determine temporal relationships, cause-effect paradigms, and the efficacy of specific clinical interventions in the context of other conditions, interventions, and goals of care. At Indiana University and the Regenstrief Institute, the investigators have four decades of experience and a well-documented, world-class clinical informatics and research infrastructure for capturing, storing, querying and analyzing treatment patterns and patients' clinical outcomes. The maturation of this health information technology is now embodied within the Indiana Network for Patient Care (INPC), a fully-operational regional health information exchange. The investigators are well positioned to expand and leverage this infrastructure in support of local and national multi-site clinical trials in comparative effectiveness. The specific aims of this proposal are to: 1.0 PROSPECT STUDY: Enhance our existing information technology infrastructure to: 1. provide de-identified access to the INPC database for CER work 2. capture, store, and track a broader array of health care outcomes important to patients and their caregivers (e.g. behavioral symptoms due to dementia); 3. support providers' and caregivers' and researchers' increasing need to work in teams by providing new tools for communication and co-management (e.g. collaborative care and research) 2.0 COMET-AD STUDY: Conduct comparative effectiveness clinical trial of medication treatment for behavioral symptoms of Alzheimer's disease in a group of real-world memory care clinics with enhanced access to the Indiana Network for Patient Care.", 
    "endDate": "2015-10-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT01362686", 
    "keywords": [
      "comparative effectiveness research", 
      "conduct", 
      "comparative effectiveness", 
      "medication treatment", 
      "behavioral symptom", 
      "Alzheimer's", 
      "disease", 
      "real world", 
      "enhanced access", 
      "patient care", 
      "overarching goal", 
      "information technology infrastructure", 
      "Indiana", 
      "nation", 
      "capacity", 
      "Instructional Film and Video", 
      "RFA", 
      "Cooperative Behavior", 
      "Medical Informatics", 
      "Inc", 
      "world leader", 
      "Indiana University", 
      "research program", 
      "aging research", 
      "division", 
      "clinical pharmacology", 
      "established track record", 
      "under-served population", 
      "environment", 
      "research strength", 
      "investigator use", 
      "definition", 
      "synthesis", 
      "benefit", 
      "harm", 
      "different intervention", 
      "diagnose", 
      "health condition", 
      "real-world setting", 
      "clinical trial", 
      "infrastructure", 
      "stress", 
      "enhancement", 
      "portfolio", 
      "array", 
      "priority condition", 
      "privacy", 
      "confidentiality", 
      "country", 
      "de-identified data", 
      "summary", 
      "Alzheimer Disease", 
      "information technology", 
      "wide range", 
      "derivation", 
      "evidence", 
      "capturing", 
      "accurate data", 
      "treatment decision", 
      "clinical status", 
      "care process", 
      "health outcome", 
      "temporal relationship", 
      "paradigm", 
      "efficacy", 
      "clinical intervention", 
      "condition", 
      "intervention", 
      "care", 
      "informatics", 
      "research infrastructure", 
      "storing", 
      "querying", 
      "treatment pattern", 
      "patient clinical outcome", 
      "maturation", 
      "health information exchange", 
      "leverage", 
      "multi-site clinical trial", 
      "prospect", 
      "Enhance", 
      "access", 
      "store", 
      "Track and Field", 
      "broad array", 
      "health care outcome", 
      "patient", 
      "caregiver", 
      "dementia", 
      "provider", 
      "team", 
      "tool", 
      "communication", 
      "co-management", 
      "collaborative care", 
      "AD"
    ], 
    "name": "Comparative Effectiveness Research Trial of Alzheimer's Disease Drugs", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT01362686"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:24", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00010.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.417143.4", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.448342.d", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.413404.6", 
        "type": "Organization"
      }, 
      {
        "id": "https://www.grid.ac/institutes/grid.257410.5", 
        "type": "Organization"
      }
    ], 
    "startDate": "2011-04-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "https://doi.org/10.1001/jama.295.18.2148", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019908788"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/cia.s5358", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032557215"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11606-005-0103-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041697782", 
          "https://doi.org/10.1007/s11606-005-0103-7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1745-6215-14-125", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053431579", 
          "https://doi.org/10.1186/1745-6215-14-125"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/jgs.14827", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084214922"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT01362686"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT01362686'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT01362686'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT01362686'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT01362686'


 

This table displays all metadata directly associated to this object as RDF triples.

141 TRIPLES      16 PREDICATES      120 URIs      105 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT01362686 schema:about anzsrc-for:2790
2 anzsrc-for:3177
3 schema:description Conduct a comparative effectiveness clinical trial of medication treatment for behavioral symptoms of Alzheimer's disease in a group of real-world memory care clinics with enhanced access to the Indiana Network for Patient Care. Detailed Description The overarching goal of this proposal is to enhance the existing information technology infrastructure in Central Indiana to improve the nation's capacity to conduct comparative effectiveness research (CER). Consistent with the instructions in RFA-HS-10-005, the investigators propose to apply these new capacities to a novel CER project evaluating treatment for Alzheimer's disease. Alzheimer's disease has been identified as a first quartile CER priority. This proposal represents collaboration between the Medical Informatics Program at the Regenstrief Institute, Inc (a world leader in health information technology) and two Indiana University research programs: the Center for Aging Research and the Division of Clinical Pharmacology. These programs have an established track record in research relevant to under-served populations. Thus, this proposal combines considerable investigator, environment, and research strengths to continue to build a novel CER infrastructure in support of the nation's evidentiary CER priorities. Throughout this proposal, the investigators use the AHRQ definition of CER: the conduct and synthesis of research comparing the benefits and harms of different interventions and strategies to prevent, diagnose, treat and monitor health conditions in real world settings." The investigators also refer to a clinical trial of medication treatment for behavioral symptoms of Alzheimer's disease as the specific CER proposed to demonstrate the potential of our new infrastructure. However, the investigators stress that the enhancements proposed to existing infrastructure would support a broad portfolio of CER across an array of priority conditions. The investigators are also proposing enhancements in our privacy and confidentiality technology that would allow researchers from across the country to access de-identified data in support of CER. In summary, the investigators are proposing to add new CER knowledge on Alzheimer' disease and thereby field test new information technology capacities important to a wide range of CER projects while also increasing our capacity to provide data and opportunities for nationwide CER. The derivation of meaningful and actionable evidence from CER ultimately depends on capturing relevant, comprehensive and accurate data about treatment decisions, patients' clinical status, their care processes and environment, and the health outcomes they experience and value. Such data must be tracked longitudinally in order to determine temporal relationships, cause-effect paradigms, and the efficacy of specific clinical interventions in the context of other conditions, interventions, and goals of care. At Indiana University and the Regenstrief Institute, the investigators have four decades of experience and a well-documented, world-class clinical informatics and research infrastructure for capturing, storing, querying and analyzing treatment patterns and patients' clinical outcomes. The maturation of this health information technology is now embodied within the Indiana Network for Patient Care (INPC), a fully-operational regional health information exchange. The investigators are well positioned to expand and leverage this infrastructure in support of local and national multi-site clinical trials in comparative effectiveness. The specific aims of this proposal are to: 1.0 PROSPECT STUDY: Enhance our existing information technology infrastructure to: 1. provide de-identified access to the INPC database for CER work 2. capture, store, and track a broader array of health care outcomes important to patients and their caregivers (e.g. behavioral symptoms due to dementia); 3. support providers' and caregivers' and researchers' increasing need to work in teams by providing new tools for communication and co-management (e.g. collaborative care and research) 2.0 COMET-AD STUDY: Conduct comparative effectiveness clinical trial of medication treatment for behavioral symptoms of Alzheimer's disease in a group of real-world memory care clinics with enhanced access to the Indiana Network for Patient Care.
4 schema:endDate 2015-10-01T00:00:00Z
5 schema:keywords AD
6 Alzheimer Disease
7 Alzheimer's
8 Cooperative Behavior
9 Enhance
10 Inc
11 Indiana
12 Indiana University
13 Instructional Film and Video
14 Medical Informatics
15 RFA
16 Track and Field
17 access
18 accurate data
19 aging research
20 array
21 behavioral symptom
22 benefit
23 broad array
24 capacity
25 capturing
26 care
27 care process
28 caregiver
29 clinical intervention
30 clinical pharmacology
31 clinical status
32 clinical trial
33 co-management
34 collaborative care
35 communication
36 comparative effectiveness
37 comparative effectiveness research
38 condition
39 conduct
40 confidentiality
41 country
42 de-identified data
43 definition
44 dementia
45 derivation
46 diagnose
47 different intervention
48 disease
49 division
50 efficacy
51 enhanced access
52 enhancement
53 environment
54 established track record
55 evidence
56 harm
57 health care outcome
58 health condition
59 health information exchange
60 health outcome
61 informatics
62 information technology
63 information technology infrastructure
64 infrastructure
65 intervention
66 investigator use
67 leverage
68 maturation
69 medication treatment
70 multi-site clinical trial
71 nation
72 overarching goal
73 paradigm
74 patient
75 patient care
76 patient clinical outcome
77 portfolio
78 priority condition
79 privacy
80 prospect
81 provider
82 querying
83 real world
84 real-world setting
85 research infrastructure
86 research program
87 research strength
88 store
89 storing
90 stress
91 summary
92 synthesis
93 team
94 temporal relationship
95 tool
96 treatment decision
97 treatment pattern
98 under-served population
99 wide range
100 world leader
101 schema:name Comparative Effectiveness Research Trial of Alzheimer's Disease Drugs
102 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT01362686
103 schema:sdDatePublished 2019-03-07T15:24
104 schema:sdLicense https://scigraph.springernature.com/explorer/license/
105 schema:sdPublisher N2d25c1e65ac945cba95d065ce74ddaee
106 schema:sponsor https://www.grid.ac/institutes/grid.257410.5
107 https://www.grid.ac/institutes/grid.413404.6
108 https://www.grid.ac/institutes/grid.417143.4
109 https://www.grid.ac/institutes/grid.448342.d
110 schema:startDate 2011-04-01T00:00:00Z
111 schema:subjectOf sg:pub.10.1007/s11606-005-0103-7
112 sg:pub.10.1186/1745-6215-14-125
113 https://doi.org/10.1001/jama.295.18.2148
114 https://doi.org/10.1111/jgs.14827
115 https://doi.org/10.2147/cia.s5358
116 schema:url https://clinicaltrials.gov/show/NCT01362686
117 sgo:license sg:explorer/license/
118 sgo:sdDataset clinical_trials
119 rdf:type schema:MedicalStudy
120 N2d25c1e65ac945cba95d065ce74ddaee schema:name Springer Nature - SN SciGraph project
121 rdf:type schema:Organization
122 anzsrc-for:2790 schema:inDefinedTermSet anzsrc-for:
123 rdf:type schema:DefinedTerm
124 anzsrc-for:3177 schema:inDefinedTermSet anzsrc-for:
125 rdf:type schema:DefinedTerm
126 sg:pub.10.1007/s11606-005-0103-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041697782
127 https://doi.org/10.1007/s11606-005-0103-7
128 rdf:type schema:CreativeWork
129 sg:pub.10.1186/1745-6215-14-125 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053431579
130 https://doi.org/10.1186/1745-6215-14-125
131 rdf:type schema:CreativeWork
132 https://doi.org/10.1001/jama.295.18.2148 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019908788
133 rdf:type schema:CreativeWork
134 https://doi.org/10.1111/jgs.14827 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084214922
135 rdf:type schema:CreativeWork
136 https://doi.org/10.2147/cia.s5358 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032557215
137 rdf:type schema:CreativeWork
138 https://www.grid.ac/institutes/grid.257410.5 schema:Organization
139 https://www.grid.ac/institutes/grid.413404.6 schema:Organization
140 https://www.grid.ac/institutes/grid.417143.4 schema:Organization
141 https://www.grid.ac/institutes/grid.448342.d schema:Organization
 




Preview window. Press ESC to close (or click here)


...